Observation Versus Treatment in Men with Prostate Cancer

July 24, 2014
Peter Yu, MD

Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men’s treatment decisions after seeing a rise in their PSA levels. <

Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men’s treatment decisions after seeing a rise in their PSA levels.

Clinical Pearls:

  • One of the studies presented at the 2014 ASCO Annual Meeting reviewed data of men who decided to wait or pursue treatment.
  • Results of this study showed there was no difference in survival regardless of their decision.
  • Men and doctors can now better discuss remaining on observation or starting treatment.